Business Context and Reporting Period
Company: Oragenics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: October 7, 2004
Reporting Period: Single event date (October 7, 2004)
Oragenics, Inc., a Florida-based corporation, filed this report to disclose a material change in its stock listing status under Regulation FD.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and listing status rather than financial performance.
Material Changes
- Stock Listing Change: Oragenics, Inc. announced it will de-list its common stock from the TSX Venture Exchange.
- New Listing Venue: The company will solely list its shares on the American Stock Exchange (AMEX).
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific risk factors. The disclosure is limited to the immediate action of changing the primary stock exchange listing.
Investor Verification Checklist
- Confirm the effective date of the de-listing from the TSX Venture Exchange.
- Verify the ticker symbol and trading status on the American Stock Exchange.
- Review the attached Press Release (Exhibit 99.1) for additional context on the strategic rationale for the exchange change.